Modern anticoagulants in the treatment and prevention of thrombotic complications in patients with Hodgkin’s lymphoma
Introduction. Cancer patients have a high risk of developing venous thromboembolic complications, which worsen the outcomes of antitumor treatment and are the second leading cause of death after cancer progression. Objectives – to assess the effect of modern a…